OHSU Funding Alerts: Week of December 10, 2020

Each week, OHSU Research Development compiles a list of funding opportunities from internal sources, the government and private foundations. We publish the list here every Thursday. A pdf of the list is also available.

Featured Opportunities 
Multidisciplinary
MRF Research Grants
What:
Supports promising biomedical exploration and the development of research careers in clinical investigation in Oregon through their Early Clinical Investigator Award,  New Investigator Grant and, along with OHSU, Emergency Interim Funding and Bridge Funding
Who should apply: Dependent upon award applied to; view CAP listings for more details
Award: Between $30 and 50,000/one year

Deadline: Dec. 15, 2020, 11:59 p.m. PT
Apply through the CAP


Environmental Health NIEHS Outstanding New Environmental Scientist (ONES) Award (R01 Clinical Trial Optional)
What: Supports Early Stage Investigators (ESIs) who intend to make a long-term commitment to research in the environmental health sciences by assisting them in launching an innovative research program focused on understanding the effects of environmental exposure on people’s health
Who should apply: NIH defined Early Stage Investigators with tenure-track or equivalent faculty appointments
Award: Up to $2.375 million/up to five years
Deadline: Internal submission due: Dec. 29, 2020; LOI due: Jan. 26, 2021, 2 p.m. PT (LOI not required but highly encouraged); Application due: Feb. 26, 2021, 2 p.m. PT
Apply through the CAP

MultidisciplinaryNSF Research Traineeship (NRT) Program
What: 
Supports proposals that explore ways for graduate students in research-based master’s and doctoral degree programs to develop the skills, knowledge and competencies needed to pursue a range of STEM careers
Who should apply: Anyone with a research interest in research traineeship
Award: Up to $3 million/up to three years
Deadline: Internal submission: Dec. 30, 2020; Application due: Feb. 25, 2021, 5 p.m. PT
Apply through the CAP


Neurology Alzheimer’s Drug Discovery Foundation Funding Opportunities
What:
Supports translational research to develop new drugs and build preclinical evidence, IND-enabling studies and early-stage clinical trials for novel and repurposed drugs, development and validation of plasma, CSF, neuroimaging and digital biomarkers and epidemiological studies and comparative effectiveness research; several funding mechanisms available
Who should apply: Depends on which funding mechanism you apply for but widely open

Award: Between $600,000 and $3 million/between one and multiple years

Deadline: For Core Funding: LOI due: Feb. 5, 2021, 2 p.m. PT; Application due: April 16, 2021, 2 p.m. PT; For Partner Funding: LOI due: Feb. 5, 2021, 2 p.m. PT; Application due: March 19, 2021, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

Internal Opportunities 

Multidisciplinary ‖ OCTRI Mobile Apps for Clinical Studies (MACS)
What: 
Funding to leverage new the REDCap functionality MyCap to create mobile apps that allow clinical study participants to report outcomes/data via a smartphone; the program aims to help fill the pipeline for BIP Digital Health by allowing PIs to conduct preliminary research and obtain user experience data
Who should apply: PIs who meet OHSU Principal Investigator requirements and want to create a mobile app for clinical or commercial purposes
Award:
Up to $5,000/typically one year
Deadline: Rolling; application will close when funding for the fiscal year is exhausted
Submit your project intake form through REDCap 

Multidisciplinary MRF Early Clinical Investigator Award
What: Funding to further the development postdoctoral fellows or trainees who interact with human subjects and who are interested in a career in clinical research
Who should apply: Postdoctoral trainees and fellows with specific plans for a career in clinical research
Award:
Up to $30,000/one year
Deadline: Dec. 15, 2020, 11:59 p.m. PT
Apply through the CAP

Multidisciplinary MRF New Investigator Grant
What: Supports promising investigators in biomedical research at the beginning of their independent careers
Who should apply: Assistant professors or equivalent who are independent but new to research and don’t yet have funding sources
Award:
Up to $50,000/one year
Deadline: Dec. 15, 2020, 11:59 p.m. PT
Apply through the CAP

Multidisciplinary MRF and OHSU Emergency Interim Support and Bridge Funding
What: Provides funding for research programs that have lost national grant funding and enables investigators to develop data supporting application renewals; OHSU applicants can apply for both MRF Emergency Interim Support and OHSU Bridge Funding
Who should apply: Researchers who need funding to keep their programs going
Award:
Up to $50,000 from both MRF and Bridge funding/one year
Deadline: Dec. 15, 2020, 11:59 p.m. PT
Apply through the CAP

Multidisciplinary Circle of Giving Women’s Health Research Funding Opportunity
What: Supports new or established investigators interested in developing innovative directions in research that will advance women’s health
Who should apply: Faculty who are at the rank of lecturer or assistant, associate, or full professor
Award:
$125,000/one year
Deadline: Jan. 8, 2021, 5 p.m. PT
Apply through the CAP

Cancer CEDAR NIH Catalyst Funding
What: Funding designed to help scientists pursuing CEDAR relevant research address reviewer concerns and resubmit their proposals to the National Institutes of Health
Who should apply:
Applicants to NIH awards who received a score but were not funded
Award:
Up to $250,000/one year
Deadline: Applications accepted anytime

Multidisciplinary OHSU Fellowship for Diversity in Research
What: Funds researchers with the goal of increasing the diversity of the community of scholars devoted to academic scientific research at OHSU
Who should apply: Investigators with postdoctoral training experience looking to establish an independent academic research career; scholars who identify as underrepresented minorities, differently-abled and more are welcomed
Award: Up to $8,000 plus a stipend
Deadline: Applications accepted anytime

Multidisciplinary  OHSU School of Medicine IDEA Seed Grants for Innovation, Development & Exploration for research Advancement
What: Supports investigators who need to work with an OHSU core or with the Pacific Northwest National Laboratory (PNNL) to develop preliminary data for an application for extramural research support
Who should apply: School of Medicine faculty in the professorial series who have not received this award within the last year
Award: Up to $5,000/one year
Deadline: Applications accepted anytime
Apply through the CAP

Multidisciplinary OHSU School of Medicine Innovation Fund Pilot Program 
What: Subsidizes fees for use of OHSU research cores to develop pilot data for new grant applications
Who should apply: School of Medicine faculty
Award: Up to $5,000
Deadline: Applications accepted anytime

Limited Submission Opportunities 

Multidisciplinary ‖ NIDDK Understanding the Cellular and Molecular Mechanisms of Gastroparesis in Adults and Children (R01 Clinical Trial Not Allowed)
What: Supports investigators from several disciplines, including basic and translational research in areas of neurosciences, immunology, microbiology and physiology, to contribute new insights into the cellular and molecular mechanisms of gastroparesis
Who should apply: Anyone with a research interest in the underlying cellular and molecular pathophysiology of gastroparesis
Award: Up to $1.25 million/up to five years
Deadline: Internal submission due: Dec. 10, 2020; LOI due: Feb. 3, 2021, 2 p.m. PT (LOI not required but highly encouraged); Application due: March 3, 2021, 2 p.m. PT
Apply through the CAP

Deadline updated
Cancer Mary Kay Foundation Cancer Research Grants
What: Seeks to further translational research in ovarian, uterine, breast or cervical cancer to improve diagnosis, prognosis, prevention or treatment of those cancers
Who should apply: Full time assistant professors or higher
Award: $100,000/two years
Deadline: Internal submission due: Dec. 11, 2020; Application due: Feb. 5, 2021, 9:59 p.m. PT
Apply through the CAP

Multidisciplinary  Ono Pharma Foundation Breakthrough Science Initiative Awards Program
What: Supports high-risk and high-reward science research projects, particularly projects about technical innovations and chemical biology research that provide solutions to human health barriers
Who should apply: Young and/or mid-career scientists (15 years or less from start of independent academic position) who has no previous relationship with the Ono Pharma Foundation; PIs also may not apply for funding to amplify current work
Award: Up to $1.035 million/up to three years
Deadline: Internal submission due: Dec. 18, 2020; LOI due: Feb. 18, 2021, 2 p.m. PT; Application due: May 18, 2021, 2 p.m. PT
Apply through the CAP

Cancer  NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers
What: Funding to increase and maintain a strong cohort of new, talented and NCI-supported independent investigators; includes RFA-CA-20-055 (K99/R00 – Independent Basic Experimental Studies with Humans Required)RFA-CA-20-056 (K99/R00 – Independent Clinical Trial Not Allowed) and RFA-CA-20-057 (K99/R00 – Independent Clinical Trial Required)
Who should apply: Mentored postdocs in cancer research with no more than two years of postdoctoral research experience
Award: Up to $650,000 plus indirect costs/up to five years
Deadline: Internal submission: Dec. 28, 2020; Application due: Feb. 26, 2021, 5 p.m. PT
Apply through the CAP

Environmental Health NIEHS Outstanding New Environmental Scientist (ONES) Award (R01 Clinical Trial Optional)
What: Supports Early Stage Investigators (ESIs) who intend to make a long-term commitment to research in the environmental health sciences by assisting them in launching an innovative research program focused on understanding the effects of environmental exposure on people’s health
Who should apply: NIH defined Early Stage Investigators with tenure-track or equivalent faculty appointments
Award: Up to $2.375 million/up to five years
Deadline: Internal submission due: Dec. 29, 2020; LOI due: Jan. 26, 2021, 2 p.m. PT (LOI not required but highly encouraged); Application due: Feb. 26, 2021, 2 p.m. PT
Apply through the CAP

New this week!
Multidisciplinary NSF Research Traineeship (NRT) Program
What: Supports proposals that explore ways for graduate students in research-based master’s and doctoral degree programs to develop the skills, knowledge and competencies needed to pursue a range of STEM careers
Who should apply: Anyone with a research interest in research traineeship
Award: Up to $3 million/up to three years
Deadline: Internal submission: Dec. 30, 2020; Application due: Feb. 25, 2021, 5 p.m. PT
Apply through the CAP

Multidisciplinary Vascular Cures Wylie Scholar Program
What: Provides development grants to vascular surgeon-scientists in the early stages of their careers
Who should apply: Active clinical vascular surgeons who are full-time faculty and are not currently funded by a career development award from the NIH, Veterans Affairs, American Heart Association or similar extramural funding agencies
Award: $150,000/up to three years
Deadline: Internal submission due: Jan. 8, 2021; Application due: Likely March 2021
This competition has not yet been announced by Vascular Cures. Dates and guidelines are subject to change.
Apply through the CAP

Cancer Cancer Research Institute Irvington Postdoctoral Fellowship Program
What: Provides support to fund and train young immunologists and cancer immunologists at top universities and research centers around the world
Who should apply: Postdocs working in immunology or cancer immunology fields who will have a doctoral degree by the date of award activation and will not have more than five years of postdoc experience
Award: $175,500/three years
Deadline: Internal submission due: Feb. 1, 2021, 11:59 p.m. PT; Application due: April 1, 2021
Apply through the CAP

Multidisciplinary Association of American Medical Colleges Herbert W. Nickens Faculty Fellowship
What: Supports junior faculty members who demonstrate leadership potential in addressing inequity in medical education and health care
Who should apply: Full-time assistant professors who have held their position from no earlier than July 1, 2017 and have received only one appointment as assistant professor
Award: $25,000/one year
Deadline: Internal submission due: Feb. 2, 2021, 11:59 p.m. PT; Application due: April 2, 2021
Apply through the CAP

Multidisciplinary NIH Prize for Enhancing Faculty Gender Diversity in Biomedical and Behavioral Science
What: Recognizes institutions whose biomedical and behavioral science departments, centers or divisions have achieved sustained improvement in gender diversity
Who should apply: Anyone whose department has demonstrable improvement in its gender diversity
Award: $50,000
Deadline: Internal submission due: Feb. 2, 2021; Application due: April 16, 2021, 2 p.m. PT
Apply through the CAP

New this week!
Cancer V Foundation V Scholar Cancer Research Grant
What: Supports tenure track faculty early in their cancer research by funding a variety of projects, from laboratory based fundamental to bench to bedside research
Who should apply: 
Tenure-track assistant professors who have been in their position for less than five years and have at least two years of postdoctoral training
Award:
Up to $200,000/up to two years
Deadline: Internal submission: Feb. 2, 2021; Application due: Likely April 2021
This competition has not yet been announced by Vascular Cures. Dates and guidelines are subject to change.
Apply through the CAP

New this week!
Cancer V Foundation Translational Cancer Research Grant Program
What: Supports translational adult cancer projects that move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms
Who should apply: Tenure-track and tenured cancer research faculty who are U.S. citizens or have a temporary or permanent legal permit to work in the U.S.
Award: Up to $600,000/up to three years
Deadline: Internal submission: Feb. 16, 2021; Application due: Likely April 2021
This competition has not yet been announced by Vascular Cures. Dates and guidelines are subject to change.
Apply through the CAP

Merit Prizes and Awards 

Multidisciplinary NOSTER and Science Microbiome Prize
What: Honors research by young investigators working on the functional attributes of the microbiota of any organism that has potential to contribute to our understanding of human or veterinary health and disease or to guide therapeutic interventions
Who should apply: Investigators who are younger than 35, received their degree in the last 10 years and submitting work that was performed in the last three years
Award: $25,000
Deadline: Jan. 24, 2021

Multidisciplinary  Lasker Foundation Lasker Awards
What: Honors fundamental biological discoveries and clinical advances that improve human health, and to draw attention to the importance of public support of science; award categories are Basic Research, Clinical Research and Special Achievement
Who should apply: Anyone who has made an original and significant contribution in basic or clinical medical research or in public service
Award: Not specified
Deadline: Feb. 1, 2021

Multidisciplinary  Science & PINS Prize for Neuromodulation
What: Honors innovative research that modulates neural activity through physical (electrical, magnetic, optical) stimulation of targeted sites in the nervous system with implications for translational medicine
Who should apply: Investigators who are younger than 45, received their degree in the last 10 years and submitting work that was performed in the last three years
Award: $25,000
Deadline: March 15, 2021

NIH Federal Opportunities

This week the NIH released funding opportunities concerning cancer, genomes and kidney medicine. We’ve highlighted some opportunities of potential interest below.

Opportunities for current grantees

Cancer NCI Revision Applications to Support the Application of Informatics Technology for Cancer Research
What: Calls for revision applications from currently funded NCI research projects; mechanisms are: (R01 Clinical Trials Optional), (U01 Clinical Trials Optional) and (U24 Clinical Trial Optional)
Deadline: For R01 and U01: LOI due: May 8, 2020 (LOI not required but highly encouraged); Application due: June 8, 2021, 5 p.m. PT; For U24: LOI due: May 9, 2020 (LOI not required but highly encouraged); Application due: June 9, 2021, 5 p.m. PT 

Other opportunities 

Multidisciplinary NHLBI Program Project Applications (P01 Clinical Trial Optional)
What: Supports programs that address scientific areas relevant to the NHLBI mission including the biology and diseases of the heart, blood vessels, lung, and blood; blood resources; and sleep disorders
Who should apply: Research scientists of recognized stature in their scientific discipline with demonstrated ability to ensure quality control, administrative oversight and integration of all program components
Award: Up to $8.825 million/up to five years
Deadline: Jan. 25, 2021, 5 p.m. PT

Substance Abuse NHGRI NOSI: High-throughput Molecular and Cellular Phenotyping
What: Solicitation for applications focused on developing novel methods to perform high-throughput molecular and cellular phenotyping in order to elucidate the functional consequences of DNA variation
Who should apply: Dependent upon FOA you apply through
Award: Dependent upon FOA you apply through  
Deadline: Open from Feb. 5, 2021 through Jan. 10, 2024

Cancer NCI Informatics Technologies for Cancer Research and Management
What: Supports development of informatics technologies to improve data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis and early cancer detection through four mechanisms: Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional); Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional); Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional); Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Who should apply: Anyone with a research interest in cancer informatics technologies
Award: For Advanced: Up to $3 million/up to five years; For Development: Up to $275,000/up to two years; For Early-Stage: Up to $900,000/up to three years; For Sustained: Not limited/up to five years   
Deadline: LOI due: May 8, 2021 (LOI not required but highly encouraged); Application due: June 8, 2021, 5 p.m. PT

Ophthalmology NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)
What: Funding to encourage institutions to propose creative and innovative institutional research career development programs which prepare clinically trained vision scientists for independent research careers
Who should apply: Established investigators in vision science who are capable of providing both administrative and scientific leadership to the proposed program
Award: Not limited/up to five years
Deadline: June 9, 2021, 5 p.m. PT

Substance Abuse NIAAA NOSI: Advances in Research for the Treatment, Services, and Recovery of Alcohol Use Disorder
What: Solicitation to advance research on various topics that fall within NIAAA’s Division of Treatment and Recovery Research (DTRR) such as health services, behavioral therapies, mechanisms of behavioral change and recovery
Who should apply: Dependent upon FOA you apply through
Award: Dependent upon FOA you apply through  
Deadline: Open through Sept. 8, 2023

Multidisciplinary NHLBI and NIEHS NOSI: Stimulating Intervention Research to Reduce Cardiopulmonary Impacts of Particulate Matter in Air Pollution among High-Risk Populations
What: Solicitation for applications aiming to investigate the impact of personal interventions to reduce exposure to particulate matter in air pollution on cardiovascular and pulmonary (cardiopulmonary) outcomes
Who should apply: Dependent upon FOA you apply through
Award: Dependent upon FOA you apply through  
Deadline: Open through Sept. 7, 2025 
  

Other Federal Opportunities 

Multidisciplinary NSF Mid-scale Research Infrastructure-2 (Mid-scale RI-2)
What:
Supports infrastructure projects at the lower and higher ends of infrastructure scales across science and engineering research disciplines
Who should apply: Anyone with a research interest in infrastructure projects
Award: Between $20 and 100 million/up to five years
Deadline: LOI due: Feb. 3, 2021 5 p.m. PT; Preliminary proposal due: March 5, 2021, 5 p.m. PT; Application due: Sept. 20, 2021, 5 p.m. PT

Bioengineering NSF Reproducible Cells and Organoids via Directed-Differentiation Encoding (RECODE)
What: Supports proposals that elucidate mechanisms of, and develop strategies to, direct the differentiation of undifferentiated cells into mature, functional cells or organoids
Who should apply: Tenured or tenure-track faculty who have a continuing appointment that is expected to last for the duration of a RECODE grant and substantial research responsibilities; the project must be related to the PI’s job responsibilities as well as to the mission of the department or organization
Award: Award size and duration are subject to the availability of fund; $10.6 million total funds estimated to be available
Deadline: Preliminary proposal due: Feb. 18, 2021, 5 p.m. PT; Application due: May 18, 2021, 5 p.m. PT

Private Opportunities

Dermatology Pfizer Advances in Atopic Dermatitis & Alopecia Areata for Community Pharmacists & Managed Care Health Care Professionals
What: Supports educational projects that focus on the role of community pharmacists and managed care health professionals and address knowledge gaps specific to care management of atopic dermatitis and alopecia areata
Who should apply:
Anyone with a research interest in atopic dermatitis and alopecia areata
Award: Up to $300,000/two years
Deadline: Jan. 12, 2021, 8:59 p.m. PT

Multidisciplinary Data for Health Initiative Global Grants Program
What: Supports projects that strengthen the collection, analysis and use of high-quality data in public health decision-making
Who should apply: Ministries of health, statistical and other relevant agencies at the national, subnational or municipal levels in low- and middle-income countries that have not received funding from the Data for Health Initiative
Award: Up to $150,000/up to one and a half years
Deadline: Jan. 15, 2021, 9 p.m. PT

Sports Medicine American College of Sports Medicine Clinical Sports Medicine Endowment
What: Supports research related to active care of athletes including prevention strategies, treatment protocols, pathogenesis, pathophysiology, biomechanics or environmental issues
Who should apply:
ACSM-member medical professionals involved in the conduct of patient-based clinical research
Award: $5,000/one year
Deadline: Jan. 22, 2021, 8:59 p.m. PT

Sports Medicine American College of Sports Medicine NASA Space Physiology Research Grant
What: Funding from NASA to support research in the areas of exercise, weightlessness and musculoskeletal physiology
Who should apply:
ACSM-member doctoral students who are U.S. citizens or permanent residents
Award: Up to $5,306/one year
Deadline: Jan. 22, 2021, 8:59 p.m. PT

Sports Medicine American College of Sports Medicine Paffenbarger-Blair Fund for Epidemiological Research on Physical Activity
What: Supports early-career researchers investigating the epidemiology of physical activity; applications can focus on observational studies of physical activity and health outcomes or randomized controlled trials that are clearly focused on physical activity and public health issues
Who should apply:
ACSM members who are within two years of receiving their postgraduate degree or completion of their clinical training and are U.S. citizens or permanent residents
Award: $10,000/one year
Deadline: Jan. 22, 2021, 8:59 p.m. PT

Psychology American Psychological Association Div. 37 Diane J. Willis Early Career Award
What: Supports a young psychologist making contributions toward informing, advocating for, and improving mental health of children and families, especially through policy
Who should apply: Psychologists who are no more than ten years postdoctoral
Award: $2,000/one year
Deadline: Jan. 31, 2021

Mental Health American College Health Foundation College Well-Being Funding Opportunity
What: Funding to create or improve underlying campus infrastructure in a way that improves the well-being of students through creative programming and outcomes research initiatives
Who should apply: ACHA institutional or individual members
Award: Up to $3,500/one year
Deadline: Feb. 1, 2021

Neurology Alzheimer’s Drug Discovery Foundation Funding Opportunities
What: Supports translational research to develop new drugs and build preclinical evidence, IND-enabling studies and early-stage clinical trials for novel and repurposed drugs, development and validation of plasma, CSF, neuroimaging and digital biomarkers and epidemiological studies and comparative effectiveness research; several funding mechanisms available
Who should apply: Depends on which funding mechanism you apply for but widely open
Award: Between $600,000 and $3 million/between one and multiple years
Deadline: For Core Funding: LOI due: Feb. 5, 2021, 2 p.m. PT; Application due: April 16, 2021, 2 p.m. PT; For Partner Funding: LOI due: Feb. 5, 2021, 2 p.m. PT; Application due: March 19, 2021, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

Infectious Disease Bay Area Lyme Foundation 2021 Emerging Leader Awards
What: Recognizes both established and up-and-coming researchers bringing new approaches and creative thinking to the field of Lyme disease through two mechanisms
Who should apply:
Early-career researchers who are currently at postdoctoral through assistant professor level or equivalent and associate professors or above
Award: For early-career: $100,000/up to one and a half years; For established: $250,000/up to two years
Deadline: Feb. 15, 2021, midnight PT

Dermatology Pfizer Inflammatory and Immune-Mediated Dermatologic Disorders
What: Supports preclinical, clinical and outcomes research with the intent to increase medical knowledge in the diagnosis and management of inflammatory and immune-mediated dermatologic disorders
Who should apply:
Anyone with a research interest in inflammatory and immune-mediated dermatologic disorders
Award: Up to $175,000/not specified
Deadline: Feb. 24, 2021, 8:59 p.m. PT

Hematology Pfizer 2021 Global Hemophilia ASPIRE# Competitive Grant Program
What: Supports research on basic and clinical science of gene therapy for hemophilia, basic and clinical science of tissue factor pathway inhibitor and anti-TFPI monoclonal antibodies and clinical hemophilia A and B
Who should apply:
Hemophilia researchers; for young investigator awards, who have received their degree within the last seven years
Award: Up to $90,000/up to two years
Deadline: March 1, 2021, 8:59 p.m. PT

Gastroenterology Angelman Syndrome Foundation Call for Research to Address Gastrointestinal Complications
What: Supports foundational research that will guide insights and eventual therapeutic development for gastrointestinal complications in Angelman Syndrome 
Who should apply:
Anyone with a research interest in gastroenterology and Angelman Syndrome
Award: Up to $100,000/up to two years
Deadline: March 15, 2021, 9:59 p.m. PT                  

Previously Published Opportunities

Federal 

December 

MultidisciplinaryMultiple NIH Opportunities Research Supplements to Promote Diversity in Health-Related Research (Admin Supp – Clinical Trial Not Allowed) Deadline: Varies by awarding IC

MultidisciplinaryDefense Advanced Research Projects Agency Young Faculty Award Technical Volume I due: Dec. 14, 2020, 1 p.m. PT; Application due: March 18, 2021, 1 p.m. PT

Cancer NCI Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) Application due: Dec. 15, 2020, 5 p.m. PT

MultidisciplinaryNCI and NIEHS New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed) and CEECR Coordinating Center (U24 Clinical Trial Not Allowed) LOI due: Dec. 15, 2020 (LOI not required but highly encouraged); Application due: Jan. 29, 2021, 5 p.m. PT 

Ophthalmology NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trial Not Allowed) LOI due: Dec. 15, 2020 (LOI not required but highly encouraged); Application due: Jan. 15, 2020, 5 p.m. PT

MultidisciplinaryNIEHS Pediatric and Reproductive Environmental Health Scholars program (K12 Independent Clinical Trial Not Allowed) LOI due: Dec. 15, 2020 (LOI not required but highly encouraged); Application due: Jan. 15, 2021, 5 p.m. PT

MultidisciplinaryNIMH and NIMHD Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection (R01 Clinical Trial Optional) LOI due: Dec. 15, 2020 (LOI not required but highly encouraged); Application due: Jan. 15, 2021, 5 p.m. PT

Infectious Disease NIMHD Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required) LOI due: Dec. 15, 2020 (LOI not required but highly encouraged); Application due: Jan. 15, 2021, 5 p.m. PT

Neuroscience  NSF Integrative Strategies for Understanding Neural and Cognitive Systems (NCS) LOI due (for FRONTIERS only): Dec. 15, 2020, 5 p.m. PT; Application due: Feb. 15, 2021, 5 p.m. PT

HIV/AIDS CDC Implementation Research Consortium to Accelerate Impact of Health Department-Delivered HIV Prevention Activities LOI due: Dec. 17, 2020; Application due: Jan. 28, 2021, 2 p.m. PT

MultidisciplinaryMultiple NIH Organizations NIH Blueprint for Neuroscience Research: Functional Neural Circuits of Interoception (R01, Clinical Trial Not Allowed) Application due: Dec. 18, 2020, 5 p.m. PT

Cancer NCI Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed) LOI due: Dec. 20, 2020 (LOI not required but highly encouraged); Application due: Jan. 20, 2021, 5 p.m. PT

MultidisciplinaryNIDDK Education Program Grants (R25 Clinical Trial Not Allowed) and Research Education Program Utilizing Stimulating Peripheral Activity to Relieve Conditions (SPARC) – Generated Resources (R25 Clinical Trial Not Allowed) For SPARC: Application due: Dec. 22, 2020, 5 p.m. PT; For regular grants: LOI due: Dec. 28, 2020 (LOI not required but highly encouraged); Application due: Jan. 28, 2021, 5 p.m. PT

MultidisciplinaryNCI and NIDCR Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, 2023 (P50 Clinical Trial Required) LOI due: Dec. 25, 2020 (LOI not required but highly encouraged); Application due: Jan. 25, 2021, 5 p.m. PT

Substance Abuse NIAAA Resource-Related Research Projects (R24 Clinical Trial Not Allowed) LOI due: Dec. 25, 2020 (LOI not required but highly encouraged); Application due: Jan. 25, 2021, 5 p.m. PT

Neurology NINDS Research Education Programs for Residents and Fellows in Neurological Disorders and Stroke (R25 – Clinical Trial Not Allowed) LOI due: Dec. 25, 2020 (LOI not required but highly encouraged); Application due: Jan. 25, 2021, 5 p.m. PT

January 2021

Multidisciplinary NIA MD-PhD Training Program in Alzheimer’s Disease and Its Related Dementias and the Behavioral and Social Sciences (T32) LOI due: Jan. 3, 2020 (LOI not required but highly encouraged); Application due: Feb. 3, 2021, 5 p.m. PT

Aging NIA Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) LOI due: Jan. 3, 2021 (LOI not required but highly encouraged); Application due: Feb. 3, 2021, 5 p.m. PT

HIV/AIDS  NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional) LOI due: Jan. 3, 2021 (LOI not required but highly encouraged); Application due: Feb. 3, 2021, 5 p.m. PT

Cancer NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) and Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) Application due: Jan. 4, 2021, 5 p.m. PT

Infectious Disease NIAID Cohort Studies To Improve Our Understanding of Influenza Immunity, Vaccine Response and Effectiveness in Older Adults (65 years and older) (U01 Clinical Trial Not Allowed) LOI due: Jan. 4, 2021 (LOI not required but highly encouraged); Application due: Feb. 4, 2021, 5 p.m. PT

Cancer NCI Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) and Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) LOI due: Jan. 5, 2021 (LOI not required but highly encouraged); Application due: Feb. 5, 2021, 5 p.m. PT

Neurology NIA Alzheimer’s Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) LOI due: Jan. 5, 2021 (LOI not required but highly encouraged); Application due: Feb. 5, 2021, 5 p.m. PT

Biomedical NLM Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed) LOI due: Jan. 5, 2021 (LOI not required but highly encouraged); Application due: Feb. 5, 2021, 5 p.m. PT

MultidisciplinaryNIDDK Catalyst Award (DP1 Clinical Trial Not Allowed) Application due: Jan. 6, 2021, 5 p.m. PT

MultidisciplinaryHRSA Maternal and Child Health (MCH) Leadership, Education, and Advancement in Undergraduate Pathways (LEAP) Training Program Deadline: Jan. 7, 2021, 8:59 p.m. PT

MultidisciplinaryNHLBI Multidisciplinary Approaches to HIV-Associated Comorbidities and Prioritizing Intervention Targets (R01 Clinical Trial Not Allowed) Application due: Jan. 7, 2021, 5 p.m. PT

Multidisciplinary NIAID A Multidisciplinary Approach to Study Vaccine-elicited Immunity and Efficacy against Malaria (U01 Clinical Trial Not Allowed) LOI due: Jan. 8, 2020 (LOI not required but highly encouraged); Application due: Feb. 8, 2021, 5 p.m. PT

MultidisciplinaryNIDA, NIMH and NINDS Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01 Clinical Trial Not Allowed) and (R21 Clinical Trial Not Allowed) Application due: Jan. 8, 2021, 5 p.m. PT

Mental Health NIMH and ORWH Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional) LOI due: Jan. 9, 2021 (LOI not required but highly encouraged); Application due: Feb. 9, 2021, 5 p.m. PT

Multidisciplinary Multiple NIH Organizations BRAIN Initiative: Pilot resources for brain cell type-specific access and manipulation across vertebrate species (U01 Clinical Trial Not Allowed) LOI due: Jan. 11, 2021 (LOI not required but highly encouraged); Application due: Feb. 11, 2021, 5 p.m. PT

Infectious Disease NIAID Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection (R01 Clinical Trial Not Allowed) LOI due: Jan. 11, 2021 (LOI not required but highly encouraged); Application due: Feb. 11, 2021, 5 p.m. PT

MultidisciplinaryNIEHS RESolution of InflammaTion in EnvirOnmentally Related diseasE (RESTORE) (R01 Clinical Trial Not Allowed) LOI due: Jan. 11, 2021 (LOI not required but highly encouraged); Application due: Feb. 11, 2021, 5 p.m. PT

Infectious Disease NIAID Coccidioidomycosis Collaborative Research Centers (U19 Clinical Trial Not Allowed) LOI due: Jan. 18, 2020 (LOI not required but highly encouraged); Application due: Feb. 18, 2021, 5 p.m. PT

Urology NIDDK GenitoUrinary Development Molecular Anatomy Project (GUDMAP) – Atlas Projects (U01 Clinical Trial Not Allowed) and Reconfiguration of GenitoUrinary Development Molecular Anatomy Project (GUDMAP) /(Re)Building A Kidney (RBK) Data Hub (U24 Clinical Trial Not Allowed) LOI due: Jan. 18, 2021 (LOI not required but highly encouraged); Application due: Feb. 18, 2021, 5 p.m. PT

Mental Health NIMH Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) and (R34 Clinical Trial Optional) LOI due: Jan. 18, 2021 (LOI not required but highly encouraged); Application due: Feb. 18, 2021, 5 p.m. PT

Urology CDC Epidemiologic Cohort Study of Interstitial Cystitis Application due: Jan. 19, 2021, 8:59 p.m. PT

MultidisciplinaryMultiple NIH Organizations NOSI: Synthetic Biology for Biomedical Applications Multiple deadlines ranging from Jan. 19, 2021 through Oct. 4, 2024

Multidisciplinary NIH Common Fund Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) LOI due: Jan. 19, 2021 (LOI not required but highly encouraged); Application due: Feb. 19, 2021, 5 p.m. PT

MultidisciplinaryNIH Common Fund Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) LOI due: Jan. 19, 2021 (LOI not required but highly encouraged); Application due: Feb. 19, 2021, 5 p.m. PT

Cancer NCI Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional), (U01 Clinical Trial Optional), (U54 Clinical Trials Optional), (P50 Clinical Trial Optional) and (P01 Clinical Trial Optional) LOI due: Jan. 22, 2020 (LOI not required but highly encouraged); Application due: Feb. 22, 2021, 5 p.m. PT

Cancer NCI Technologies for Basic and Clinical Cancer Research FOAs Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed); Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed); Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed); Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) LOI due: Jan. 22, 2021 (LOI not required but highly encouraged); Application due: Feb. 22, 2021, 5 p.m. PT

MultidisciplinaryMultiple NIH Organizations Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required) and (R01 Clinical Trial Not Allowed) Deadline: Jan. 26, 2021, 5 p.m. PT

MultidisciplinaryNLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) LOI due: Jan. 26, 2021 (LOI not required but highly encouraged); Application due: Feb. 26, 2021, 5 p.m. PT

February 2021

Substance Abuse  NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) LOI due: Feb. 1, 2021 (LOI not required but highly encouraged); Application due: March 1, 2021, 5 p.m. PDT

Multidisciplinary NIA and NINDS Treatments for Lewy Body Dementias–Exploratory Clinical Trial (U01 Clinical Trial Required) LOI due: Feb. 2, 2021 (LOI not required but highly encouraged); Application due: March 2, 2021, 5 p.m. PT

Multidisciplinary NIDDK Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional) LOI due: Feb. 3, 2021 (LOI not required but highly encouraged); Application due: March 3, 2021, 5 p.m. PT

Rheumatology NIAMS Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed), Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) and Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) LOI due (for U01 only): Feb. 4, 2021 (LOI not required but highly encouraged); Application due: March 4, 2021, 5 p.m. PT

MultidisciplinaryMultiple NIH Organizations Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional) and Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed) For Clinical Trial Not Allowed: Feb. 5, 2021, 5 p.m. PT; For Clinical Trial Optional: May 7, 2021, 5 p.m. PT

MultidisciplinaryMultiple NIH Organizations Discovery of Cell-based Chemical Probes for Novel Brain Targets (R21 Clinical Trial Not Allowed) and Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) For R01: Feb. 5, 2021, 5 p.m. PT; For R21: Feb. 16, 2021, 5 p.m. PT

MultidisciplinaryMultiple NIH Organizations NOSI: Academy of Finland (AKA) – National Institutes of Health (NIH) Partnership Program Rolling from Feb. 5, 2021 through Jan. 8, 2024

Dentistry NIDCR National Dental Practice-Based Research Network Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional) Application due: Feb. 9, 2021, 5 p.m. PT; subsequent rounds due in June and Oct. 2021

Multidisciplinary  Multiple NIH Organizations BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed) LOI due: Feb. 10, 2021 (LOI not required but highly encouraged); Application due: March 10, 2021, 5 p.m. PT

Neurology NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed) Deadline: Feb. 11, 2021, 5 p.m. PT

MultidisciplinaryMultiple NIH Organizations Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp – Clinical Trial Not Allowed) Deadline: Feb. 15, 2021, 5 p.m. PT; subsequent due date May 15, 2021

Cancer NCI and ODP Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required) LOI due: Feb. 15, 2021 (LOI not required but highly encouraged); Application due: March 15, 2021, 5 p.m. PT

Multidisciplinary NIAAA and NIDA Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed) LOI due: Feb. 15, 2021 (LOI not required but highly encouraged); Application due: March 15, 2021, 5 p.m. PT

MultidisciplinaryNIAID HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) LOI due: Feb. 15, 2021 (LOI not required but highly encouraged); Application due: March 15, 2021, 5 p.m. PT

Dentistry NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) Deadline: Feb. 16, 2021, 5 p.m. PT

Emergency Medicine NIGMS Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collections (R21/R33 – Clinical Trial Not Allowed) Deadline: Feb. 16, 2021, 5 p.m. PT

Biomedicine NSF Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) Deadline: Feb. 16, 2021, 5 p.m. PT

Multidisciplinary Multiple NIH Organizations Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed) LOI due: Feb. 17, 2021 (LOI not required but highly encouraged); Application due: March 17, 2021, 5 p.m. PT

Multidisciplinary  NIAID and NIMH New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed) LOI due: Feb. 17, 2021 (LOI not required but highly encouraged); Application due: March 17, 2021, 5 p.m. PT

Cancer NCI Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) and (UH3 Clinical Trials Not Allowed) Deadline: Feb. 18, 2021, 5 p.m. PT

Multidisciplinary  NIAMS Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) and (R21 Clinical Trial Not Allowed) LOI due: Feb. 18, 2020 (LOI not required but highly encouraged); Application due: March 18, 2021, 5 p.m. PT

March 2021

MultidisciplinaryMultiple NIH Organizations Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) Deadline: March 5, 2021, 5 p.m. PT

MultidisciplinaryNIAID and NICHD Development of the Fetal Immune System (R01 Clinical Trial Not Allowed) LOI due: March 7, 2021 (LOI not required but highly encouraged); Application due: April 7, 2021, 5 p.m. PT

April 2021

Multidisciplinary NSF Non-Academic Research Internships for Graduate Students (INTERN) Supplemental Funding Opportunity Deadline: April 15, 2021

Multidisciplinary Multiple NIH Organizations Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) and (R21 Clinical Trial Not Allowed) LOI due: April 17, 2021 (LOI not required but highly encouraged); Application due: May 17, 2021, 5 p.m. PT

Mental Health NIMH Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) LOI due: April 17, 2021 (LOI not required but highly encouraged); Application due: May 17, 2021, 5 p.m. PT

Multidisciplinary  Multiple NIH Organizations Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed) LOI due: April 26, 2021 (LOI not required but highly encouraged); Application due: May 26, 2021, 5 p.m. PDT

MultidisciplinaryNIAAA Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Optional), Administrative Resource Core (U24) (Clinical Trial Optional) and Research Resource (U24) (Clinical Trial Optional) Deadline: LOI due: April 26, 2021, 5 p.m. PT; Application due: May 26, 2021, 5 p.m. PT

Drug Abuse NIDA Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) Deadline: April 30, 2021, 5 p.m. PT

May 2021

MultidisciplinaryMultiple NIH Organizations Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional) Deadline: May 7, 2021, 5 p.m. PT

June 2021

MultidisciplinaryNCI, NIAAA and NIDA Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) and (R34 Clinical Trial Optional) LOI due: June 19, 2021 (LOI not required but highly encouraged); Application due: July 19, 2021, 5 p.m. PT

August 2021

Multidisciplinary NIMH Developmental AIDS Research Centers on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) and NIMH AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) LOI due: Aug. 13, 2020 (LOI not required but highly encouraged); Application due: Aug. 25, 2021, 5 p.m. PT

Open

Genomics  NHGRI Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed) Applications are accepted by continuous receipt

Biology NSF Biophotonics Applications accepted anytime

Biology NSF Cellular and Biochemical Engineering Applications accepted anytime

Biology  NSF Dear Colleague Letter: Conferences for Building Computational Literacy in Biological Sciences Deadline: Open

Biology NSF Division of Integrative Organismal Systems Core Programs Applications accepted anytime

Biology NSF Division of Molecular and Cellular Biosciences: Investigator-initiated research projects (MCB) Deadline: Open

Multidisciplinary NSF Enabling Discovery through GEnomic Tools (EDGE) Deadline: Open

Biology NSF Infrastructure Innovation for Biological Research (Innovation) Deadline: Open

Biology NSF Transitions to Excellence in Molecular and Cellular Biosciences Research (Transitions) Deadline: Open

Private 

December 

Surgery American Society of Breast Surgeons Foundation Research Grants Deadline: Dec. 11, 2020, 8:59 p.m. PT

NeurologyMichael J. Fox Foundation ASAP Collaborative Research Network: Circuitry and Brain-body Interactions Deadline: Pre-proposal due: Dec. 11, 2020, 2 p.m. PT; Full proposal due: April 13, 2021, 2 p.m. PT

Neurology Misophonia Research Fund Misophonia Research Grants Deadline: LOI due: Dec. 11, 2020, 9:59 p.m. PT; Application due: March 12, 2021, 9:59 p.m. PT

MultidisciplinaryAtomwise AIMS Award Program Deadline: Dec. 14, 2020

Women’s Health American College of Obstetricians and Gynecologists Warren H. Pearse Women’s Health Policy Research Award Deadline: Dec. 15, 2020

Rhinology American Rhinologic Society Grants LOI due: Dec. 15, 2020, 8:59 p.m. PT; Application due: Jan. 15, 2021, 8:59 p.m. PT

Multidisciplinary Foundation for a Smoke-free World COVID-19, Smoking, and Nicotine Research Deadline: Dec. 15, 2020, 5 a.m. PT

Cancer Alex’s Lemonade Stand Foundation RUNX1 Early Career Investigator Grant Program Deadline: Dec. 16, 2020, 5 p.m. PT

Cancer American Association for Cancer Research AACR-Bristol Myers Midcareer Female Investigator Grant Deadline: Dec. 17, 2020, 10 a.m. PT

MultidisciplinaryNational Academies of Sciences, Engineering, and Medicine Ford Foundation Fellowship Programs Predoctoral applications: Dec. 17, 2020, 2 p.m. PT

Multidisciplinary Robert Wood Johnson Foundation Health Data for Action: (Data Access Award) Brief proposal due: Dec. 17, 2020, noon PT; Full proposal due: April 15, 2021, noon PT
This organization is on the President’s List; submit a notice of intent form before applying

Cancer American Association for Cancer Research AACR-QuadW Foundation Fellowship for Clinical/Translational Sarcoma Research Deadline: Dec. 18, 2020, 10 a.m. PT

Cancer Elsa U. Pardee Foundation Research Grants Deadline: Dec. 31, 2020

Cancer Health and Environmental Science Institute THRIVE Grants Deadline: LOI due: Dec. 31, 2020; Application due: March 15, 2021

January 2021

Anesthesiology Anesthesia Patient Safety Foundation APSF-FAER Mentored Research Training Grant LOI due: Jan. 1, 2021; Application due: Feb. 15, 2021

Cancer Children’s Tumor Foundation Young Investigator Award LOI due: Jan. 1, 2021, 2 p.m. PT; Application due: March 5, 2021, 2 p.m. PT

Psychology American Psychological Association Congressional Fellowship Deadline: Jan. 4, 2021

Neuroscience  McKnight Endowment Fund for Neuroscience 2021 McKnight Scholar Awards Deadline: Jan. 4, 2021

Multidisciplinary Doris Duke Charitable Foundation Physician Scientist Fellowship Deadline: Jan. 5, 2021, noon PT

UrologyAmerican Urological Association Urology Care Foundation Summer Medical Student Fellowship Deadline: Jan. 7, 2021, 2 p.m. PT

Mental Health Klingenstein Third Generation Foundation Addressing Access to Care Deadline: Jan. 10, 2021, 8:59 p.m. PT

Orthopedics Orthopaedic Trauma Association OTA Member Full Research Grant Preproposal due: Jan. 11, 2021; Application due: Mid-June 2021

Orthopedics Orthopaedic Trauma Association Resident Research Grant Preproposal due: Jan. 11, 2021; Application due: Mid-June 2021 

Neurology American Epilepsy Society Postdoctoral Research Fellowships Deadline: Jan. 13, 2021

Cancer Bladder Cancer Advocacy Network Bladder Cancer Research Innovation Awards Deadline: Jan. 13, 2021, 2 p.m. PT

MultidisciplinaryNational Psoriasis Foundation More than Skin Deep: Mental Health Grant and Fellowships Program Deadline: Jan. 13, 2021, 5 p.m. PT

Dermatology National Psoriasis Foundation Psoriatic Disease Research Fellowships Deadline: Jan. 13, 2021, 5 p.m. PT

Dermatology National Psoriasis Foundation Research Grants Program Deadline: Jan. 13, 2021, 5 p.m. PT

MultidisciplinaryBurroughs Wellcome Fund Postdoctoral Enrichment Program Deadline: Jan. 14, 2021, 1 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

Nursing Johnson & Johnson Nurses Innovate QuickFire Challenge on Mental Health Deadline: Jan. 15, 2021

MultidisciplinaryNew York Academy of Medicine David E. Rogers Student Fellowship Award Deadline: Jan. 15, 2021

Cancer American Institute for Cancer Research Investigator-Initiated Research Grant Program LOI due: Jan. 22, 2021; Application due: May 14, 2021

Urology American Urological Association Urology Care Foundation Summer Medical Student Fellowship Deadline: Jan. 22, 2021, 8:59 p.m. PT

Multidisciplinary L’Oréal USA For Women in Science Deadline: Jan. 29, 2021, 8:59 p.m. PT

February 2021

Molecular Science Chan Zuckerberg Initiative Visual Proteomics Imaging Deadline: Feb. 17, 2021, 5 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

March 2021

Cancer Mark Foundation Endeavor Awards Deadline: LOI due: March 1, 2021; Application due: July 2021
This organization is on the President’s List; submit a notice of intent form before applying

Open

Substance Abuse Charles Koch Foundation Substance Abuse Research Grants Deadline: Rolling

Neurology Cure SMA Newborn Screening for Spinal Muscular Atrophy Program Deadline: Rolling

Pulmonology Cystic Fibrosis Foundation Path to a Cure: Industry Award Program Deadline: Rolling, but LOI required

Multidisciplinary Robert Wood Johnson Foundation Evidence for Action: Investigator-Initiated Research to Build a Culture of Health Deadline: Open
This organization is on the President’s List; submit a notice of intent form before applying

Multidisciplinary Robert Wood Johnson Foundation Pioneering Ideas: Exploring the Future to Build a Culture of Health Deadline: Rolling
This organization is on the President’s List; submit a notice of intent form before applying

Ophthalmology SFARI Supplement to Enhance Equity and Diversity (SEED) Deadline: Rolling
This organization is on the President’s List; submit a notice of intent form before applying

Leave a Reply